METROPOLITAN ST.LOUIS PSYCH CENTER
1. Target Overview & Investment Thesis
METROPOLITAN ST.LOUIS PSYCH CENTER is a 50-bed under-performing / distressed in ST. LOUIS CITY, MO with $5.6M in net patient revenue and a -38.1% operating margin. The hospital serves a payer mix of 9.4% Medicare, 7.8% Medicaid, and 82.8% commercial.
Thesis: Turnaround. Our ML models identify $425K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -38.1% to -30.5% (+756bps).
| Net Revenue HCRIS | $5.6M |
| Current EBITDA COMPUTED | $-2.1M |
| Operating Margin COMPUTED | -38.1% |
| Occupancy HCRIS | 93.9% |
| Revenue / Bed COMPUTED | $113K |
| Net-to-Gross HCRIS | 83.3% |
| Distress Probability ML | 45.5% |
2. Market Context & Competitive Position
MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -38.1% places it below the state median. Among 68 size-comparable peers (25-100 beds), the median margin is -7.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (25-100), prioritizing same-state peers. 68 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| METROPOLITAN ST.LOUIS PSYCH CE (Target) | MO | 50 | $5.6M | -38.1% |
| HANNIBAL REGIONAL HOSPITAL | MO | 86 | $226.2M | -6.8% |
| CAPITAL REGION MEDICAL CENTER | MO | 100 | $224.0M | -17.7% |
| BARNES JEWISH WEST COUNTY HOSP | MO | 68 | $221.1M | 4.9% |
| CITIZENS MEMORIAL HOSPITAL DIS | MO | 52 | $178.3M | -19.3% |
| LEES SUMMIT MEDICAL CENTER | MO | 80 | $146.7M | 13.6% |
| GOLDEN VALLEY MEMORIAL HOSPITA | MO | 42 | $139.8M | -4.9% |
| PROGRESS WEST HOSPITAL | MO | 69 | $112.0M | 11.7% |
| MISSOURI DELTA MEDICAL CENTER | MO | 98 | $110.9M | -24.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $425K (756bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $118K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $117K | +207bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $113K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $68K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +17bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-2.1M |
| + RCM Uplift | +$425K |
| Pro Forma EBITDA | $-1.7M |
| Current Margin | -38.1% |
| Pro Forma Margin | -30.5% |
| WC Released (1x) | $216K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-3.3M | $-9.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-3.3M | $-12.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-3.0M | $-11.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-3.0M | $-13.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-3.6M | $-10.9M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-3.6M | $-13.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 68 hospitals with 25-100 beds
- Same-state prioritization (n=69)
- Comp margins: P25=-15.9% / P50=-7.6% / P75=6.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.